Document is current
Any future updates will be listed below
-
Authors
Seaman, William T.
Keener, Olive
Nanayakkara, Dinelka
Mollan, Katie R.
Premkumar, Lakshmanane
Cuadra, Edwing Centeno
Jones, Corbin D.
Pettifor, Audrey
Bowman, Natalie M.
,
Wohl, David
Wolfgang, Matt
Markmann, Alena
Hoffman, Erin
Kronk, Catherine
Mitchem, Olivia
O′Reilly, Camille
de Silva, Aravinda
Lovell, Will
Phillips, S. T.
Ramsey, Kathy
Blake, Jo-Ann
Maile, Rob
Wang, Frank
Webster-Cyriaque, Jennifer
-
Funding
Funding for this research was provided by:
National Institutes of Health (NCI U54CA260543-01)
North Carolina General Assembly (subdivision (23) of Section 3.3 of Session Law 2020-4)
National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 9 July 2023
Accepted: 11 July 2024
First Online: 18 September 2024
Competing interests
: Potential conflicts of interest: Frank Wang is employed by BioMedomics, Inc, the manufacturer of the N-antigen and anti-SARS-CoV-2 Spike RBD protein IgG/IgM LFA cartridges used in this study. No other authors declare any conflicts of interest.
